Your browser doesn't support javascript.
loading
Plasma levels of guanylins are reduced in patients with Crohn's disease.
von Volkmann, Hilde L; Brønstad, Ingeborg; Tronstad, Rune R; Dizdar, Vernesa; Nylund, Kim; Hanevik, Kurt; Hausken, Trygve; Gilja, Odd Helge; Fiskerstrand, Torunn.
Afiliación
  • von Volkmann HL; National Centre for Ultrasound in Gastroenterology, Department of Medicine, Haukeland University Hospital.
  • Brønstad I; Department of Clinical Medicine, University of Bergen.
  • Tronstad RR; National Centre for Ultrasound in Gastroenterology, Department of Medicine, Haukeland University Hospital.
  • Dizdar V; Department of Clinical Medicine, University of Bergen.
  • Nylund K; Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
  • Hanevik K; Department of Clinical Science, University of Bergen, Bergen, Norway.
  • Hausken T; National Centre for Ultrasound in Gastroenterology, Department of Medicine, Haukeland University Hospital.
  • Gilja OH; National Centre for Ultrasound in Gastroenterology, Department of Medicine, Haukeland University Hospital.
  • Fiskerstrand T; Norwegian National Advisory Unit on Tropical Infectious Diseases, Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Scand J Gastroenterol ; 55(4): 449-453, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32306784
ABSTRACT

Background:

Guanylin (GN) and uroguanylin (UGN) are endogenous ligands for the intestinal receptor guanylate cyclase C (GC-C), an important regulator of intestinal fluid homeostasis. Gene expression and protein levels of GN are suppressed in inflamed intestinal tissue from patients with inflammatory bowel disease (IBD), but knowledge about plasma levels of guanylins in these conditions is sparse. We aimed to investigate the fasting plasma levels of the prohormones proGN and proUGN in patients with Crohn's Disease (CD) and relate these to levels found in persons with other diarrheal conditions, as well as persons with normal bowel habits.

Methods:

Plasma from patients with CD, patients with Familial GUCY2C Diarrheal Disease (FGDS), diarrhea-predominant irritable bowel syndrome (IBS-D) and healthy controls (HC) was analyzed using ELISA assays.

Results:

Significantly lower fasting plasma levels of proguanylins were found in CD and FGDS patients, compared to HC. In CD patients, plasma proGN levels correlated negatively with Harvey Bradshaw Index and with number of stools/24 h.

Conclusion:

Our data indicate that diarrhea may be a determinant for levels of proGN in plasma, and should be further explored in studies of different diarrheal disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Síndrome del Colon Irritable / Péptidos Natriuréticos / Diarrea / Hormonas Gastrointestinales Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Gastroenterol Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn / Síndrome del Colon Irritable / Péptidos Natriuréticos / Diarrea / Hormonas Gastrointestinales Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Gastroenterol Año: 2020 Tipo del documento: Article